168 related articles for article (PubMed ID: 33967624)
1. The impact of Aurora kinase A genetic polymorphisms on cervical cancer progression and clinicopathologic characteristics.
Wu PJ; Wang CH; Hsieh MH; Lee CY; Wang PH; Lin CW; Yang SF; Lee MS
Int J Med Sci; 2021; 18(11):2457-2465. PubMed ID: 33967624
[TBL] [Abstract][Full Text] [Related]
2. Impact of matrix metalloproteinase-11 gene polymorphisms on development and clinicopathologcial variables of uterine cervical cancer in Taiwanese women.
Ng SC; Wang PH; Lee YC; Lee CY; Yang SF; Shen HP; Hsiao YH
Int J Med Sci; 2019; 16(6):774-782. PubMed ID: 31337950
[TBL] [Abstract][Full Text] [Related]
3. Impact of
Sun YH; Chou YH; Wang CH; Hsiao YH; Lee CY; Yang SF; Wang PH
Int J Med Sci; 2021; 18(11):2339-2346. PubMed ID: 33967610
[TBL] [Abstract][Full Text] [Related]
4. Combined effect of genetic polymorphisms of AURKA and environmental factors on oral cancer development in Taiwan.
Chou CH; Chou YE; Chuang CY; Yang SF; Lin CW
PLoS One; 2017; 12(2):e0171583. PubMed ID: 28152093
[TBL] [Abstract][Full Text] [Related]
5. Relationship of genetic variant distributions of WW domain-containing oxidoreductase gene with uterine cervical cancer.
Lin YH; Hsiao YH; Wu WJ; Yang SF; Hsu CF; Kang YT; Wang PH
Int J Med Sci; 2018; 15(10):1005-1013. PubMed ID: 30013442
[TBL] [Abstract][Full Text] [Related]
6. Association of Fibroblast Growth Factor Receptor 4 Genetic Polymorphisms With the Development of Uterine Cervical Cancer and Patient Prognosis.
Chen TH; Yang SF; Liu YF; Lin WL; Han CP; Wang PH
Reprod Sci; 2018 Jan; 25(1):86-93. PubMed ID: 28378614
[TBL] [Abstract][Full Text] [Related]
7. Relationships of single nucleotide polymorphisms of monocyte chemoattractant protein 1 and chemokine receptor 2 with susceptibility and clinicopathologic characteristics of neoplasia of uterine cervix in Taiwan women.
Wu HH; Lee TH; Tee YT; Chen SC; Yang SF; Lee SK; Ko JL; Wang PH
Reprod Sci; 2013 Oct; 20(10):1175-83. PubMed ID: 23427179
[TBL] [Abstract][Full Text] [Related]
8. Impact of Aurora Kinase A Polymorphism and Epithelial Growth Factor Receptor Mutations on the Clinicopathological Characteristics of Lung Adenocarcinoma.
Yang PJ; Hsieh MJ; Lee CI; Yen CH; Wang HL; Chiang WL; Liu TC; Tsao TC; Lee CY; Yang SF
Int J Environ Res Public Health; 2020 Oct; 17(19):. PubMed ID: 33050100
[TBL] [Abstract][Full Text] [Related]
9. Effect of tissue inhibitor of metalloproteinases-3 genetics polymorphism on clinicopathological characteristics of uterine cervical cancer patients in Taiwan.
Chung JF; Chen CL; Nassef Y; Shiu BH; Wang CH; Kuo FH; Hsiao YH; Yang SF; Wang PH
Int J Med Sci; 2022; 19(6):1013-1022. PubMed ID: 35813301
[TBL] [Abstract][Full Text] [Related]
10. Investigation of metastasis-associated in colon cancer-1 genetic variants in the development and clinicopathologcial characteristics of uterine cervical cancer in Taiwanese women.
Sun YH; Chou YH; Ou CC; Ng SC; Shen HP; Lee YC; Hsu CF; Yang SF; Wang PH
Int J Med Sci; 2020; 17(4):490-497. PubMed ID: 32174779
[TBL] [Abstract][Full Text] [Related]
11. Impacts of
Huang CH; Chen CJ; Chen PN; Wang SS; Chou YE; Hung SC; Yang SF
J Cancer; 2019; 10(6):1370-1374. PubMed ID: 31031846
[TBL] [Abstract][Full Text] [Related]
12. Aurora-A affects radiosenstivity in cervical squamous cell carcinoma and predicts poor prognosis.
Ma Y; Yang J; Wang R; Zhang Z; Qi X; Liu C; Ma M
Oncotarget; 2017 May; 8(19):31509-31520. PubMed ID: 28404933
[TBL] [Abstract][Full Text] [Related]
13. Association of the AURKA and AURKC gene polymorphisms with an increased risk of gastric cancer.
Mesic A; Rogar M; Hudler P; Juvan R; Komel R
IUBMB Life; 2016 Aug; 68(8):634-44. PubMed ID: 27270838
[TBL] [Abstract][Full Text] [Related]
14. Association of an aurora kinase a (AURKA) gene polymorphism with progression-free survival in patients with advanced urothelial carcinoma treated with the selective aurora kinase a inhibitor alisertib.
Necchi A; Pintarelli G; Raggi D; Giannatempo P; Colombo F
Invest New Drugs; 2017 Aug; 35(4):524-528. PubMed ID: 28155045
[TBL] [Abstract][Full Text] [Related]
15. Mitosis is a source of potential markers for screening and survival and therapeutic targets in cervical cancer.
Espinosa AM; Alfaro A; Roman-Basaure E; Guardado-Estrada M; Palma Í; Serralde C; Medina I; Juárez E; Bermúdez M; Márquez E; Borges-Ibáñez M; Muñoz-Cortez S; Alcántara-Vázquez A; Alonso P; Curiel-Valdez J; Kofman S; Villegas N; Berumen J
PLoS One; 2013; 8(2):e55975. PubMed ID: 23405241
[TBL] [Abstract][Full Text] [Related]
16. Correlation of chitinase 3-like 1 single nucleotide polymorphisms and haplotypes with uterine cervical cancer in Taiwanese women.
Lin YS; Liu YF; Chou YE; Yang SF; Chien MH; Wu CH; Chou CH; Cheng CW; Wang PH
PLoS One; 2014; 9(9):e104038. PubMed ID: 25203433
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activation of nuclear factor κB contributes to cystic fibrosis transmembrane conductance regulator expression and promotes human cervical cancer progression and poor prognosis.
Wu Z; Peng X; Li J; Zhang Y; Hu L
Int J Gynecol Cancer; 2013 Jun; 23(5):906-15. PubMed ID: 23640294
[TBL] [Abstract][Full Text] [Related]
18. Variations in the
Wang B; Hsu CJ; Chou CH; Lee HL; Chiang WL; Su CM; Tsai HC; Yang SF; Tang CH
Int J Med Sci; 2018; 15(2):170-175. PubMed ID: 29333101
[TBL] [Abstract][Full Text] [Related]
19. Significant association of long non-coding RNAs HOTAIR genetic polymorphisms with cancer recurrence and patient survival in patients with uterine cervical cancer.
Weng SL; Wu WJ; Hsiao YH; Yang SF; Hsu CF; Wang PH
Int J Med Sci; 2018; 15(12):1312-1319. PubMed ID: 30275757
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
